Purchase Order HHSN261201800033P
Ended Awarded Last action
- Contract number
- HHSN261201800033P
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,698
Award facts
- Contract value 100% obligated
- $10,697.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339112 Surgical and Medical Instrument Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Illumina, Inc., valued at $10,697.76, on November 15, 2017, for firm fixed price delivery by November 30, 2017. Place of performance is Bethesda, Maryland. The order procures sequencing reagents, consumables, or related bioinformatics products aligned with Illumina's core portfolio of DNA and RNA sequencing instruments and supplies.
Quick answers
Who was awarded contract HHSN261201800033P?
HHSN261201800033P was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on November 15, 2017.
How much is contract HHSN261201800033P worth?
The government has obligated $10,698 on HHSN261201800033P.
Was contract HHSN261201800033P competed?
The extent of competition for HHSN261201800033P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award